Imetelstat
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Myelofibrosis
Conditions
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies
Trial Timeline
Oct 29, 2012 → May 24, 2018
NCT ID
NCT01731951About Imetelstat
Imetelstat is a phase 2 stage product being developed by Geron for Primary Myelofibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01731951. Target conditions include Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05937568 | Pre-clinical | Completed |
| NCT01916187 | Phase 1 | Withdrawn |
| NCT01731951 | Phase 2 | Completed |
| NCT01243073 | Phase 2 | Completed |
Competing Products
20 competing products in Primary Myelofibrosis